VI
NAGE

Vestcor Inc’s Niagen Bioscience NAGE Stock Holding History

Vestcor Inc’s Portfolio NAGE Stock Details NAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$78K Hold
24,457
– – ﹤0.01% 1137
2026
Q1 		$108K Hold
24,457
– – ﹤0.01% 1120
2025
Q4 		$156K Hold
24,457
– – ﹤0.01% 1004
2025
Q3 		$228K Buy
+24,457
New +$247K 0.01% 952

Other funds holding NAGE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SW
SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TCM
Tieton Capital Management Yakima, Washington $348M AUM 45.13% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vestcor Inc's NAGE Position: Q2 2026 in Review

Vestcor Inc held its Niagen Bioscience (NAGE) position steady in Q2 2026 at 24,457 shares worth $78K. The position accounts for ﹤0.01% of the portfolio, ranked #1137.

Vestcor Inc first reported a position in NAGE in Q3 2025 and has held it in 4 quarters since. The position peaked at $228K in Q3 2025. 140 funds tracked by Wall St. Rank hold NAGE as of Q2 2026.

  • Vestcor Inc held 24,457 shares of Niagen Bioscience worth $78K as of Q2 2026.
  • Vestcor Inc left its Niagen Bioscience share count unchanged in Q2 2026.
  • Niagen Bioscience made up ﹤0.01% of Vestcor Inc's portfolio in Q2 2026, its #1137 holding.
  • Vestcor Inc first reported a position in Niagen Bioscience in Q3 2025 and has held it in 4 quarters since.
  • Vestcor Inc's Niagen Bioscience position peaked at $228K in Q3 2025.
  • 140 funds tracked by Wall St. Rank held Niagen Bioscience as of Q2 2026.

Based on Vestcor Inc's 13F filing for Q2 2026, filed 11 Aug 2026.